News Feed Item

OBN Facilitates Funding to UK R&D Companies from the Biomedical Catalyst Scheme

ABINGDON, England, November 8, 2012 /PRNewswire/ --

OBN, the trade association for emerging life sciences companies, is gratified to note the recent £39 million tranche in funding awards to UK life science companies under the Biomedical Catalyst Scheme administered by the Technology Strategy Board (TSB). 

Since March 2012, OBN has held four events in Oxford, Cambridge and London where over 220 attendees from life science companies were able to meet, interact with and question the TSB staff responsible for the administration of the fund.

Senior managers from the 2012 Biomedical Catalyst Scheme winners Absynth, Glide Pharma, Arecor, Pharminox, Domainex, Summit, GeneFirst and Pharmidex all attended these OBN events.

At the second Oxford event in October this year, entitled "Learning from the Winners, How to Succeed with the Biomedical Catalyst Scheme", OBN was the first organisation to call on the UK Government to extend and expand on the industry component of the Biomedical Catalyst to £2bn over 10 years, which will help maintain the UK bioindustry's number one position in Europe.

Having presented at three of the OBN events, Dr Helen Kuhlman, Lead Technologist, Medicines and Healthcare, TSB commented, "OBN events have provided a great opportunity to reach out to exciting businesses and talk with the people responsible for developing innovative healthcare propositions about their challenges and aspirations." 

Dr Jon Rees, CEO, OBN, commented, "OBN is delighted to work with the TSB in order to ensure that its members have the best chance of funding success.  Having identified an effective scheme to stimulate innovative R&D, we hope the UK Government will build on this commitment toward ensuring the scheme is of a scale and duration sufficient to maintain the UK bioindustry's number one position in Europe."

OBN's early and comprehensive efforts on the BMC are part of our facilitation of funding for the early-stage UK life science sector that in the last year has also included presentations by partners from the Syncona Fund, Index Ventures and NeoMed to our members. In addition, OBN will host the second City Investment Network event at Baker Botts in the City of London later today, and the BMC will chair a showcase scientific session of the winners from the BMC Scheme at next year's BioTrinity conference which will be held in Newbury from the 14th to the 16th of May, 2013.

About OBN

OBN is the trade association supporting the UK's emerging life sciences companies OBN's activities can be summarised as networking, partnering, group purchasing, and providing fundraising advice. Through its delivery of Europe's fastest growing biopartnering and investment conference 'BioTrinity' OBN generates more R&D-company-to-investor interactions than anyone else in Europe. OBN runs regular 'BioTuesday' evening networking events which typically feature three speakers talking on a topic of business, financial or scientific interest, followed by two hours of networking over wine and canapés. They are attended by 70-120 delegates. In addition OBN offers an Executive Breakfast Club with up to 25 CEO's, CFO's and COO's coming together with major industry figures to discuss a topic of mutual interest in an informal way. Details of OBN's other events can be found at http://www.obn.org.uk/evens OBN can also offer our members discounted rates on lab supplies and services through more than 30 suppliers, office supplies, private medical insurance, among over 40 offers on products and services through the group OBN Purchasing Scheme.

About the BioMedical Catalyst

The BioMedical Catalyst was implemented to help UK R&D companies to access much needed funding to aid the development of innovative products and technology, in attracting private finance and ultimately to treating areas of unmet medical need. The BioMedical Catalyst, launched as a key action within the government's Strategy for UK Life Sciences and aimed at addressing market failure in the financing of early-stage innovative biomedical R&D companies in the UK, is designed to effectively translate basic research into products with market potential. This joint £180m Technology Strategy Board and Medical Research Council programme offers funding to innovative small and medium sized enterprises (SMEs) and academics looking to work either individually or in collaboration to develop solutions to healthcare challenges. The Biomedical Catalyst accepts innovative ideas from any sector or discipline that demonstrate the potential to provide significant positive healthcare and economic impact.

For further information, please contact:

Andy Smith
Director of Investor and Public Relations
Email: [email protected]
Telephone: +44(0)845-5049-715

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
According to Forrester Research, every business will become either a digital predator or digital prey by 2020. To avoid demise, organizations must rapidly create new sources of value in their end-to-end customer experiences. True digital predators also must break down information and process silos and extend digital transformation initiatives to empower employees with the digital resources needed to win, serve, and retain customers.
SYS-CON Events announced today that SoftNet Solutions will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. SoftNet Solutions specializes in Enterprise Solutions for Hadoop and Big Data. It offers customers the most open, robust, and value-conscious portfolio of solutions, services, and tools for the shortest route to success with Big Data. The unique differentiator is the ability to architect and ...
A completely new computing platform is on the horizon. They’re called Microservers by some, ARM Servers by others, and sometimes even ARM-based Servers. No matter what you call them, Microservers will have a huge impact on the data center and on server computing in general. Although few people are familiar with Microservers today, their impact will be felt very soon. This is a new category of computing platform that is available today and is predicted to have triple-digit growth rates for some ...
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
As the world moves toward more DevOps and Microservices, application deployment to the cloud ought to become a lot simpler. The Microservices architecture, which is the basis of many new age distributed systems such as OpenStack, NetFlix and so on, is at the heart of Cloud Foundry - a complete developer-oriented Platform as a Service (PaaS) that is IaaS agnostic and supports vCloud, OpenStack and AWS. Serverless computing is revolutionizing computing. In his session at 19th Cloud Expo, Raghav...
In past @ThingsExpo presentations, Joseph di Paolantonio has explored how various Internet of Things (IoT) and data management and analytics (DMA) solution spaces will come together as sensor analytics ecosystems. This year, in his session at @ThingsExpo, Joseph di Paolantonio from DataArchon, will be adding the numerous Transportation areas, from autonomous vehicles to “Uber for containers.” While IoT data in any one area of Transportation will have a huge impact in that area, combining sensor...
So you think you are a DevOps warrior, huh? Put your money (not really, it’s free) where your metrics are and prove it by taking The Ultimate DevOps Geek Quiz Challenge, sponsored by DevOps Summit. Battle through the set of tough questions created by industry thought leaders to earn your bragging rights and win some cool prizes.
SYS-CON Events announced today that Transparent Cloud Computing (T-Cloud) Consortium will exhibit at the 19th International Cloud Expo®, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. The Transparent Cloud Computing Consortium (T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data proces...
Between the mockups and specs produced by analysts, and resulting applications built by developers, there exists a gulf where projects fail, costs spiral, and applications disappoint. Methodologies like Agile attempt to address this with intensified communication, with partial success but many limitations. In his session at @DevOpsSummit at 19th Cloud Expo, Charles Kendrick, CTO at Isomorphic Software, will present a revolutionary model enabled by new technologies. Learn how business and deve...
In his session at Cloud Expo, Robert Cohen, an economist and senior fellow at the Economic Strategy Institute, will provide economic scenarios that describe how the rapid adoption of software-defined everything including cloud services, SDDC and open networking will change GDP, industry growth, productivity and jobs. This session will also include a drill down for several industries such as finance, social media, cloud service providers and pharmaceuticals.
Enterprises have been using both Big Data and virtualization for years. Until recently, however, most enterprises have not combined the two. Big Data's demands for higher levels of performance, the ability to control quality-of-service (QoS), and the ability to adhere to SLAs have kept it on bare metal, apart from the modern data center cloud. With recent technology innovations, we've seen the advantages of bare metal erode to such a degree that the enhanced flexibility and reduced costs that cl...
SYS-CON Events announced today that Niagara Networks will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
Everyone knows that truly innovative companies learn as they go along, pushing boundaries in response to market changes and demands. What's more of a mystery is how to balance innovation on a fresh platform built from scratch with the legacy tech stack, product suite and customers that continue to serve as the business' foundation. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, will discuss why and how ReadyTalk diverted from healthy revenue an...
SYS-CON Media announced today that @WebRTCSummit Blog, the largest WebRTC resource in the world, has been launched. @WebRTCSummit Blog offers top articles, news stories, and blog posts from the world's well-known experts and guarantees better exposure for its authors than any other publication. @WebRTCSummit Blog can be bookmarked ▸ Here @WebRTCSummit conference site can be bookmarked ▸ Here
Intelligent machines are here. Robots, self-driving cars, drones, bots and many IoT devices are becoming smarter with Machine Learning. In her session at @ThingsExpo, Sudha Jamthe, CEO of IoTDisruptions.com, will discuss the next wave of business disruption at the junction of IoT and AI, impacting many industries and set to change our lives, work and world as we know it.